ArticleInternational journal of cancer2025

Mass cytometric detection of homologous recombination proficiency in circulating tumor cells to predict chemoresistance of metastatic breast cancer patients.

Kathrin Niedermayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.